Adams Kendra bought CCCC
September 18, 2026 · Form 4 insider transaction
Adams Kendra bought 6,250 shares of C4 Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,250
Price
$0.00
Total value
N/A
InsiderAdams Kendra
Role—
CompanyC4 Therapeutics, Inc. (CCCC)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 18, 2026
Filing dateSeptember 21, 2026
Shares owned after385,098
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Reflects the acquisition of shares of Common Stock upon vesting of a previously disclosed grant of restricted stock units ("RSUs"). The grant of RSUs was initially reported in Table I of the Form 4 filed by the Reporting Person on September 19, 2023.